# Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/increased-fibroblast-growth-factor-21-in-chronic-kidney-disease-is-a-trade-off/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Toshihiro Nakano,Kazuhiro Shiizaki,Yutaka Miura,Masahiro Matsui,Keisei Kosaki,Shoya Mori,Kunihiro Yamagata,Seiji Maeda,Takuya Kishi,Naoki Usui,Masahide Yoshida,Tatsushi Onaka,Hiroaki Mizukami,Ruri Kaneda,Kazunori Karasawa,Kosaku Nitta,Hiroshi Kurosu,Makoto Kuro‐o |
| Citations | 17 |
| DOI | 10.1038/s41598-019-55643-4 |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41598-019-55643-4.pdf |
| OpenAlex ID | https://openalex.org/W2996557481 |
| PMID | 31848393 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Kazunori Karasawa](https://scholariq.org/researchers/kazunori-karasawa/)

## Paper journal

- [Scientific Reports](https://scholariq.org/journals/scientific-reports/)

## Paper primary topic

- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)

## Paper topics

- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Genetic Syndromes and Imprinting](https://scholariq.org/topics/genetic-syndromes-and-imprinting/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.